Building effective pharmaceutical supply chain partnerships requires intentional investment in communication, internal alignment, and structured governance to navigate an increasingly volatile industry landscape.
Sponsored by Cencora
Developing true partnerships in the pharmaceutical supply chain demands self-awareness around organizational size. Paula Pulsoni, Vice President of Service Development and Innovation at World Courier, explains how in an environment where volatility has become the norm rather than the exception, companies are advised to establish clear structures and governance frameworks that allow them to measure partnership readiness before disruption occurs. Internal alignment is identified as a critical factor, particularly for cross-functional initiatives such as sustainability, where procurement plays a central role in communicating the purpose and resource requirements of a partnership across departments. Ultimately, resilient partnerships are built on transparency, consistent communication cadence, face-to-face engagement, and a shared commitment to keeping the patient at the center of decision-making.
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
